Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Post by SouthernTierTomon Dec 16, 2021 2:01pm
177 Views
Post# 34237740

"dragging their feat" US Trials.gov way out of date...

"dragging their feat" US Trials.gov way out of date...We've heard all about the 15 sites being up and running for the Tiger...Let's get the US Trials.gov site updated as well.  I've notivced their SEDI filings are totally out of date as well, the former head of Dialco stepped down in July and still shows as an insider.  I've noticed the "invester presentation" is listed as "COMING SOON" on their webbed site, sounds like a movie poster....

The recent activity looks as though they "moved it" out of harm's way with next to NO true breadth of participation.  Simply allowing house #7 T.D. to fill their pockets and take on the retail appearance.  

We need this AGP group to step up and say something sooner rather than later.  A near 5 month chart draw clearly states that NOBODY, including our treasured insiders received ANY kind of a deal at 42.5 cents CAD....indeed ; - ) ...

Here is the outdated US Trials.gov site:

Trial record 3 of 11 for:    toraymyxin

Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study (TIGRIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03901807
Recruitment Status  : Recruiting
First Posted  : April 3, 2019
Last Update Posted  : September 14, 2021

<< Previous
Bullboard Posts
Next >>